載入...
Pancreatic biomarkers: Could they be the answer?
Pancreatic ductal adenocarcinoma (PDA) is known for its poor prognosis. Most of the patients are diagnosed with advanced stages, when no curative treatment is available. Currently, despite extensive clinical research on PDA, the median overall survival remains short. Diagnosis delay and primary chem...
Na minha lista:
| Main Authors: | , |
|---|---|
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Baishideng Publishing Group Inc
2014
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4069311/ https://ncbi.nlm.nih.gov/pubmed/24976720 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v20.i24.7819 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|